FIC
RPRX icon

FCG Investment Company’s Royalty Pharma RPRX Stock Holding History

FCG Investment Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
30,104
-6,495
-18% -$338K 0.58% 44
2026
Q1 		$1.76M Buy
+36,599
New +$1.6M 0.77% 33

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.28B AUM 47.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

FCG Investment Company's RPRX Position: Q2 2026 in Review

FCG Investment Company reduced its Royalty Pharma (RPRX) stake by 18% in Q2 2026, selling an estimated $338K and leaving 30,104 shares worth $1.69M. The position accounts for 0.58% of the portfolio, ranked #44.

FCG Investment Company first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.76M in Q1 2026. 329 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • FCG Investment Company held 30,104 shares of Royalty Pharma worth $1.69M as of Q2 2026.
  • FCG Investment Company sold 6,495 Royalty Pharma shares in Q2 2026, an estimated $338K.
  • Royalty Pharma made up 0.58% of FCG Investment Company's portfolio in Q2 2026, its #44 holding.
  • FCG Investment Company first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • FCG Investment Company's Royalty Pharma position peaked at $1.76M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.